Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127426 trials found · Page 3374 of 6372
-
New scan may spare bladder cancer patients from surgery
Diagnosis CompletedTreatment of localized muscle invasive bladder cancer (MIBC) is radical cystectomy. Neoadjuvant chemotherapy (NAC) improves survival. Approximately 50-60% of all MIBC patients undergoing NAC before cystectomy are histopathological without remnant tumor in the cystectomy specimen…
Sponsor: Jørgen Bjerggaard Jensen • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
COVID-19's hidden damage: new study scans heart, lungs, and brain
Knowledge-focused CompletedBackground: COVID-19 virus infection differs among people. Some people have no or mild symptoms. For others, COVID-19 is life threatening and causes damage to the body s organs. Researchers want to better understand the virus to learn how to kill it. Objective: To understand h…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Diet showdown: can keto or mediterranean ease psoriasis and joint pain?
Symptom relief CompletedThe aim of our study is to compare the effectiveness of Mediterranean diet (MD) with the isocaloric Ketogenic diet (KD) on clinical and biochemical markers of inflammation in patients with obesity, psoriasis (PSO) and psoriatic arthritis (PsA).
Sponsor: Attikon Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Can extra antibiotics finally knock out MRSA in the throat?
Disease control CompletedThe aim of this study is to investigate the optimal way to treat MRSA throat carriers.
Phase 3 • Sponsor: Hvidovre University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Stem cells aim to keep dialysis lifelines open
Disease control Recruiting nowResearchers are evaluating the safety of allogeneic Adipose Derived Mesenchymal Stem Cells (AMSC) use during hemodialysis arteriovenous fistula and arterial bypass creation and its efficacy on improving access maturation and primary anastomotic patency.
Phase 1 • Sponsor: Houssam Farres, M.D. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Bubble baby breakthrough? experimental cell shot aims to reboot immune system faster
Disease control CompletedThe purpose of this study is to evaluate the safety and the efficacy of Human T Lymphoid Progenitor (HTLP) injection to accelerate immune reconstitution after partially HLA compatible allogeneic hematopoietic stem cell transplantation in SCID patients.
Phase 1/2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Scientists probe immune system in severe COVID-19 to find new clues
Knowledge-focused Recruiting nowInfection with the SARS-CoV-2 coronavirus (COVID-19) has recently been identified as a pandemic due to the speed and global scale of its transmission. In Auvergne-Rhône-Alpes region (AURA), the epidemic began in February 2020 and the number of infected people is still important. …
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Genetic cheat code may unlock safer, stronger chemo cocktail for tough cancers
Disease control Recruiting nowThe purpose of the proposed study is to establish the safety of combining irinotecan chemotherapy with 5-FU, leucovorin/folinic acid, oxaliplatin, and docetaxel (abbreviated as the I-FLOAT study of gFOLFOXIRITAX) chemotherapies (leucovorin/folinic acid is a vitamin to make 5-FU w…
Phase 1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New drug combo aims to outsmart Chemo-Resistant ovarian cancer
Disease control OngoingThis phase I trial studies the side effects and best dose of peposertib when given together with pegylated liposomal doxorubicin hydrochloride in treating patients with high or low grade ovarian cancer that has come back after a period of improvement (recurrent). Peposertib may s…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New pill plus immunotherapy shows promise in early cancer trial
Disease control CompletedThis is a first-in-human Phase 1a/1b, multicenter, open-label, dose-escalation, dose and schedule optimization, and expansion study of TPST-1495 as a single agent and in combination with pembrolizumab to determine its maximum tolerated dose (MTD) and or recommended Phase 2 dose (…
Phase 1 • Sponsor: Tempest Therapeutics • Aim: Disease control
Last updated Jun 26, 2026 15:48 UTC
-
Cough medicine repurposed: ambroxol registry launches for rare brain diseases
Knowledge-focused Recruiting nowAmbroxol hydrochloride is an oral mucolytic drug available over-the-counter for many years as cough medicine. In 2009 it was found to also act as a pharmacological chaperone (PC) for mutant glucocerebrosidase, albeit in a several-fold higher dose. Unfortunately, due to its low co…
Sponsor: Shaare Zedek Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New group program aims to cut stroke risk in African-American men
Disease control CompletedThe project is a 6-month prospective Randomized Controlled Trial evaluating the effects of TargEted MAnageMent Intervention (TEAM, N=80) vs. wait-list (WL, N=80) control in African American men who have experienced a stroke or TIA within the past 5 years.
Sponsor: Case Western Reserve University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Your tongue could reveal cancer: AI study analyzes 4,100 people
Knowledge-focused CompletedThe tongue images of malignant tumors and corresponding healthy people will be collected to establish the tongue image database. Deep learning will be carried out by computer and artificial intelligence to construct the early screening, diagnosis, prognosis and prognosis model of…
Sponsor: Zhejiang Cancer Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New MRI technique could help men with prostate cancer avoid unnecessary treatment
Diagnosis By invitation onlyTo investigate whether multiparametric MRI (mp-MRI) in patients with low-risk prostate cancer can improve the selection of patients suitable for Active Surveillance and have a relevance in the ongoing monitoring
Sponsor: Herlev Hospital • Aim: Diagnosis
Last updated Jun 26, 2026 16:01 UTC
-
Experimental drug targets hard-to-treat cancers with unique marker
Disease control CompletedA single arm phase II study with 30 patients of leronlimab (PRO 140) in patients with CCR5+ locally advanced or metastatic solid tumors.
Phase 2 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Smart sensors could revolutionize rehab for amputees
Symptom relief OngoingThe goal of this research is to analyze data from smartphone-based and wearable sensors, using advanced machine-learning and data-mining techniques, and to combine this information with performance-based measures, participant-reported measures, and structured interviews to create…
Sponsor: Shirley Ryan AbilityLab • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Healthcare workers under the microscope: tracking COVID-19 spread and immunity
Knowledge-focused CompletedThe main objectives of this study are 1) to establish the prevalence of SARS-CoV-2 in asymptomatic healthcare workers (HCWs) in an early phase of community spread as well as 2) to monitor the future spread of the disease by assessing serological responses to SARS-CoV-2 in symptom…
Sponsor: University Medicine Greifswald • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Scientists launch major effort to track rare nerve disease in children
Knowledge-focused Recruiting nowThe Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia (HSP) is focused on gathering longitudinal clinical data as well as biological samples (skin and/or blood and/or saliva) from male and female patients, under the age of 30, who exhibited early on…
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New antibody drug takes on Hard-to-Treat cancers
Disease control CompletedThis is a Phase 1/1b, open-label, first-in-human, dose-escalation and expansion study of CHS-388, a monoclonal antibody that targets IL-27, as a monotherapy and in combination in patients with solid tumors.
Phase 1 • Sponsor: Coherus Oncology, Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Healthcare Workers' COVID antibodies under the microscope
Knowledge-focused Recruiting nowThe novel coronavirus (SARS-CoV-2) has spread all around the world and testing has posed a challenge globally. Health care providers are highly exposed and are an important group to test. On top of these concerns, health care workers are also stressed by the needs on responders i…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC